| Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > George Bush on Corporate CEO Pay |
|
Other Articles - George Bush on Corporate CEO Pay
President Bush has done an excellent job in lowering taxes and strengthening the economy According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product even after the Dot Com bubble burst he had to deal with and the 911 attacks which precede ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in to eliminate some 7 Trillion Dollars out of the US Stock Market, without any forewarning lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. to investors, corporations or Mutual Fund holders. Recently, President Bush gave a quick here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe speech and interview at the NY Stock Exchange on Corporate CEO pay stating that pay needs d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro to be tied to performance. Obviously, for too long Corporate CEOs have raped companies, ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc while not producing profits or growth. And yes and this speaks to the comments made by de easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi tractors about Exxon's CEO Lee and his retirement package. Talk about performance? That i nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically the largest company in the world now and the performance is unheard of. If anyone in Cor and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ porate America deserves such a retirement package he would be it. Thus what President Bu ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi h is saying is an example of Warren Buffets essays. I concur that CEO should have the sal ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ries as a base and the rest as a factor of their performance. And I think Shareholders wh dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod o own the company ought to make sure that is indeed how things play out. The shareholders cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin own the company and they ought to let that be known. I agree we do not need a crystal ba tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ll to predict the future we must be proactive to create it and these CEOs need to perform t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel and if you are doing that you deserve the pay, so, do it well! If not your base salary ou ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ght to be it and that is that. And if you do perform as a CEO then you should be entitled y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products to amass a fair amount of percentage to that which you bring to the table in performance . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de and you should be allowed to spend that money as you see fit. This is why capitalism work elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip and why breadlines suck. I hope you enjoyed the thought that this article evokes in 2007 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Chess Sets Online Retailing - Dealing with Aggressive Unethical Competition Develop Products Faster Using Proven Rapid Prototyping Technologies
|